News

Forte Biosciences (NASDAQ: FBRX) has initiated an underwritten public offering of common stock and pre-funded warrants. Certain investors may receive pre-funded warrants instead of common stock ...
HAYWARD, Calif.-- (BUSINESS WIRE)-- Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies ...
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy ...
Return on Assets (ROA): Avidity Biosciences's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -7.66%, the company may face hurdles in ...
A look at the shareholders of Pulse Biosciences, Inc. (NASDAQ:PLSE) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 73% ...
Colossal Biosciences, a biotech firm, has successfully revived the dire wolf, an Ice Age species extinct for over 12,000 years, through advanced genetic engineering and CRISPR technology. This ...
Scientists at Colossal Biosciences studied a 13,000 year-old dire wolf tooth unearthed in Ohio and a 72,000 year-old skull fragment found in Idaho, both part of natural history museum collections.
Ben Lamm celebrated his company Colossal Biosciences' successful de-extinction of the dire wolf. Learn more about the CEO here.
FDA has authorized Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs) for use in the first pediatric clinical trial, to evaluate if ...
Despite better-than-expected profitability in the fourth quarter, which it reported late last week, Neurocrine Biosciences (NBIX -0.14%) hasn't been wowing analysts lately.
Neurocrine Biosciences Q4 EPS of $1.69 beat estimates, while revenue missed consensus. Ingrezza sales rose 23% to $615 million. 2025 Ingrezza sales guidance fell short of Street estimate. Analysts ...